Structure via PubChem · Public domain (PubChem)
revaprazan
Sign in to saveRevaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis. It acts as an acid pump antagonist (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea, but is not approved in Europe or the United States.
Chemical data
- Formula
- C22H23FN4
- Molecular weight
- 362.4 g/mol
- IUPAC name
- N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine
- SMILES
- CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F
- InChIKey
- LECZXZOBEZITCL-UHFFFAOYSA-N
- XLogP
- 5.3
- Polar surface area
- 41.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- gastroesophageal reflux disease
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 362.191
Show 2 more facts
- canonical SMILES
- CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F
- chemical formula
- C₂₂H₂₃FN₄
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis. It acts as an acid pump antagonist (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea, but is not approved in Europe or the United States.
==See also== Vonoprazan
Excerpted from Wikipedia’s “revaprazan” article, available under the CC BY-SA 4.0 licence.